Timing of Methamphetamine Exposure during Adolescence Differentially Influences Parvalbumin and Perineuronal Net Immunoreactivity in the Medial Prefrontal Cortex of Female, but Not Male, Rats
Developmental Neuroscience · 2024
DOI: 10.1159/000538608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neuroscience, 2024. Verfasst von Amara S Brinks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program in Neuroscience, University of Illinois Urbana-Champaign, Champaign, Illinois, USA. Hauptthemen laut MEDLINE: Methamphetamine, Parvalbumins, Prefrontal Cortex, Central Nervous System Stimulants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Introduction
Adolescence involves significant reorganization within the medial prefrontal cortex (mPFC), including modifications to inhibitory neurotransmission that may be mediated through parvalbumin (PV) interneurons and their surrounding perineuronal nets (PNNs). These developmental changes, which can result in increased PV neuron activity in adulthood, may be disrupted by drug use resulting in lasting changes in mPFC function and behavior. Methamphetamine (METH), which is a readily available drug used by some adolescents, increases PV neuron activity, and could influence the activity-dependent maturational process of these neurons.
Methods
In the present study, we used male and female Sprague-Dawley rats to test the hypothesis that METH exposure influences PV and PNN expression in a sex- and age-specific manner. Rats were injected daily with saline or 3.0 mg/kg METH from early adolescence (30–38 days old), late adolescence (40–48 days old), or young adulthood (60–68 days old). One day following exposure, the effects of METH on PV cells and PNN expression were assessed using immunofluorescent labeling within the mPFC.
Results
METH exposure did not alter male PV neurons or PNNs. Females exposed in early adolescence or adulthood had more PV-expressing neurons while those exposed in later adolescence had fewer, suggesting distinct windows of vulnerability to changes induced by METH exposure. In addition, females exposed to METH had more PNNs and more intense PV neuron staining, further suggesting that METH exposure in adolescence uniquely influences the development of inhibitory circuits in the female mPFC.
Conclusions
This study indicates that the timing of METH exposure, even within adolescence, influences its neural effects in females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Neuroscience, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.
- Department of Psychology, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.
- Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
Förderung
- NIDA NIH HHS
Zitieren
APA
Brinks, A. S., Carrica, L. K., Tagler, D. J., Gulley, J. M., & Juraska, J. M. (2024). Timing of Methamphetamine Exposure during Adolescence Differentially Influences Parvalbumin and Perineuronal Net Immunoreactivity in the Medial Prefrontal Cortex of Female, but Not Male, Rats. Developmental Neuroscience. https://doi.org/10.1159/000538608
Vancouver
Brinks AS, Carrica LK, Tagler DJ, Gulley JM, Juraska JM. Timing of Methamphetamine Exposure during Adolescence Differentially Influences Parvalbumin and Perineuronal Net Immunoreactivity in the Medial Prefrontal Cortex of Female, but Not Male, Rats. Developmental Neuroscience. 2024. doi:10.1159/000538608
BibTeX
@article{Brinks2024,
author = {Brinks, Amara S and Carrica, Lauren K and Tagler, Dominic J and Gulley, Joshua M and Juraska, Janice M},
title = {Timing of Methamphetamine Exposure during Adolescence Differentially Influences Parvalbumin and Perineuronal Net Immunoreactivity in the Medial Prefrontal Cortex of Female, but Not Male, Rats},
journal = {Developmental Neuroscience},
year = {2024},
doi = {10.1159/000538608}
}
EUVIMED